Serum BCL2/IGH DNA in Follicular Lymphoma Patients: A Minimal Residual Disease Marker

References

• Weiss L. M., Warnke R. A., Sklar J., Cleary M. L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. New England Journal of Medicine 1987; 317: 1185–1189
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Cossman J., Jaffe E., Croce C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–1443
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Galili N., Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. Journal of Experimental Medicine 1986; 164: 315–320
   PubMed Web of Science ®Google Scholar
• Lee M. S., Chang K. S., Cabanillas F., Freireich E. J., Trujillo J. M., Stass S. A. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 1987; 237: 175–178
   PubMed Web of Science ®Google Scholar
• Berinstein N. L., Reis M. D., Ngan B. Y., Sawka C. A., Jamal H. H., Kuzniar B. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma. Journal of Clinical Oncology 1993; 11: 1344–1352
   PubMed Web of Science ®Google Scholar
• Berinstein N. L., Jamal H. H., Kuzniar B., Klock R. J., Reis M. D. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post- treatment. Leukemia 1993; 113–119
   PubMed Web of Science ®Google Scholar
• Yuan R., Dowling P., Zucca E., Diggelmann H., Cav-Alli F. Detection of bcl-2/JH rearrangement in follicular and diffuse lymphoma: concordant results of peripheral blood and bone marrow analysis at diagnosis. British Journal of Cancer 1993; 67: 922–925
   PubMed Web of Science ®Google Scholar
• Zwicky C. S., Maddocks A. B., Andersen N., Gribben J. G. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood 1996; 88: 3314–3322
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Freedman A. S., Woo S. D., Blake K., Shu R. S., Freeman G., Longtine J. A., Pinkus G. S., Nadler L. M. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275–3280
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Neuberg D., Freedman A. S., Gimmi C. D., Pesek K. W., Barber M., Saporito L., Woo S.D., Coral F, Spector N. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449–3457
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Neuberg D., Barber M., Moore J., Pesek K. W., Freedman A. S., Nadler L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 1994; 83: 3800–3807
   PubMed Web of Science ®Google Scholar
• Lambrechts A. C., Hupkes P. E., Dorssers L. C., van't Veer M. B. Clinical significance of t(14; 18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. Journal of Clinical Oncology 1994; 12: 1541–1546
   PubMed Web of Science ®Google Scholar
• Fournie G. J., Gayral-Taminh M., Bouche J. P., Conte J. I. Recovery of nanogram quantities of DNA from plasma and quantitative measurement using labeling by nick translation. Analytical Biochemistry 1986; 158: 250–256
   PubMed Web of Science ®Google Scholar
• Leon S. A., Shapiro B., Sklaroff D. M., Yaros M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Research 1977; 37: 646–650
   PubMed Web of Science ®Google Scholar
• Fournie G. J., Courtin J. P., Laval R, Chale J. J., Pourrat J. P., Pujazon M. C., Lauque D., Carles P. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Letters 1995; 91: 221–227
   PubMed Web of Science ®Google Scholar
• Kopreski M. S., Benko F. A., Kwee C., Leitzel K. E., Eskander E., Upton A., Gocke C. D. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. British Journal of Cancer 1997; 76: 1293–1299
   PubMed Web of Science ®Google Scholar
• Anker P., Lefort P., Vasioukhin V., Lyautey J., Lederrey C., Chen X. Q., Stroun M., Mulcahy H. E., Farthing M. J. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997; 112: 1114–1120
   PubMed Web of Science ®Google Scholar
• Sorenson G. D., Pribish D. M, Valone F. H., Memoli V. A., Bzik D. J., Yao S. L. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiology, Biomarkers & Prevention 1994; 3: 67–71
   PubMed Web of Science ®Google Scholar
• Vasioukhin V., Anker P., Maurice P., Lyautey J., Lederrey C., Stroun M. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. British Journal of Haematology 1994; 86: 774–779
   PubMed Web of Science ®Google Scholar
• Bendandi M., Gocke C., Kobrin C., Benko R, Sternas L., Watson T., Reynolds C., Kwak L. Molecular complete remissions induced by patient-specific vaccination in most patients with follicular lymphoma (FL). Blood 1998; 92: 153a
   Web of Science ®Google Scholar
• Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237–238
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral R, Freeman G. J. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New England Journal of Medicine 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Pesando J. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. Journal of Clinical Oncology 1994; 12: 1021–1027
   PubMed Web of Science ®Google Scholar
• Frickhofen N., Muller E., Sandherr M., Binder T., Bangerter M., Wiest C., Enz M., Heimpel H. Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. Blood 1997; 90: 4953–4960
   PubMed Web of Science ®Google Scholar
• Price C. G., Meerabux J., Murtagh S., Cotter R E., Rohatiner A. Z., Young B. D., Lister T. A. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. Journal of Clinical Oncology 1991; 9: 1527–1532
   PubMed Web of Science ®Google Scholar
• Roberts W. M., Estrov Z., Ouspenskaia M. V., Johnston D. A., McClain K. L., Zipf T. R. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. New England Journal of Medicine 1997; 336: 317–323
   PubMed Web of Science ®Google Scholar